Treatment Registry
TR-0953 ActiveRecorded October 2026

Brand semaglutide

Sold by Immortals · Oral tablet · every brand semaglutide record

Price

No comparable monthly price verified at this reading. See dated notes for any advertised starting figures.

Visit Immortals

We earn nothing from this link. It opens Immortals's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • October 2026 — Entry added to the register

Sourcing and terms

PharmacyNot disclosed
StatesNot disclosed
PrescriberBoth
CancellationCancel future subscription charges in account settings at least 24 hours before the current subscription period ends. Cancellation takes effect at the end of that period. Medicine sales are final, with no returns or refunds; contact support about a dispensing error.
MembershipNone. “No membership fees, no hidden costs. You pay only after a doctor prescribes treatment.”
Consult feeNot disclosed

Recorded from immortals.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. October 2026 — Immortals offers Wegovy tablets separately from its Wegovy injections. The tablet selection advertises a starting monthly equivalent of $1,550, billed quarterly with a three-month commitment paid upfront. This is not a pay-as-you-go monthly offer; confirm the full quarterly bill before enrolling. Physician review begins with an online intake, and some states require an audio or video consultation. There is no membership fee. Details: https://immortals.com/collections/weight-loss-prescriptions/products/wegovy

2 further notes concern other Immortals programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0953
Medication category
brand semaglutide
Readings
1

Related records

Cite this entry

Treatment Registry. (2026). Immortals — brand semaglutide (TR-0953). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0953

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.